Cargando…
Risk of Selected Cardiovascular Toxicities in Patients With Cancer Treated With MEK Inhibitors: A Comparative Systematic Review and Meta-Analysis
PURPOSE: We conducted a literature-based meta-analysis of the risk of cardiovascular toxicities associated with MEK inhibitors. METHODS: Eligible trials included randomized phase II and III trials of patients with cancer who were given a mitogen activated protein (MAP)/extracellular signal-regulated...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society of Clinical Oncology
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5539872/ https://www.ncbi.nlm.nih.gov/pubmed/28804776 http://dx.doi.org/10.1200/JGO.2015.000802 |